0.188
Abpro Holdings Inc Aktie (ABP) Neueste Nachrichten
Where Do Analysts See Abpro Holdings Inc (NASDAQ: ABP) Heading? - Stocksregister
Abpro Holdings Postpones Annual Stockholders Meeting - TipRanks
Market Momentum: Abpro Holdings Inc (ABP) Registers a 3.72 Increase, Closing at 0.22 - DWinneX
Abpro Holdings Inc Still Hasn’t Convinced Analysts? - Stocksregister
Nasdaq Top 5 Premarket Gainers: Clik Holdings, Graphjet Technology, NuCana, Ekso Bionics Holdings, Abpro Holdings - MSN
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Financial Fitness Check: Examining Abpro Holdings Inc (ABP)’s Key Ratios - DWinneX
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 By Investing.com - Investing.com India
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 - Investing.com Australia
ABP stock plunges to 52-week low, touches $0.23 - Investing.com
Holdings of Abpro Holdings Inc (ABP) are aligned with the stars - Sete News
Closing Strong: Abpro Holdings Inc (ABP) Ends at 0.26, Down -0.27 from Last Close - DWinneX
Abpro Holdings Inc’s latest rating changes from various analysts - knoxdaily.com
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - ADVFN
ABP’s Stock Journey: What Investors Need to Know About Abpro Holdings Inc’s Performance - investchronicle.com
Analyzing ABP’s price-to-book ratio for the last quarter - uspostnews.com
Abpro Holdings Presents Promising Preclinical Cancer Data - TipRanks
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager - The Manila Times
Abpro and Celltrion Reveal Promising Preclinical Data for Bispecific T-Cell Engager ABP-102/CT-P72 Targeting HER2-Positive Cancers - Nasdaq
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing - Bluefield Daily Telegraph
Cancer Drug Shows 2X Better Tumor Suppression in Breakthrough Study | ABP Stock News - Stock Titan
Abpro Holdings CEO Acquires Additional Shares - TradingView
Stocks in play: A&W Food Services of Canada Inc - The Globe and Mail
Abpro Holdings amends convertible note terms with Yorkville - Investing.com
ABP stock plunges to 52-week low, touches $0.23 By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials - Investing.com Australia
Abpro Holdings, Inc. SEC 10-K Report - TradingView
Abpro Holdings approves significant stock issuance to Yorkville - Investing.com Australia
Abpro Holdings approves significant stock issuance to Yorkville By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price - Investing.com
Abpro Holdings Delays Year-End Financial Report - TipRanks
Abpro Holdings to Present Preclinical Data at AACR 2025 - TipRanks
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - The Manila Times
Groundbreaking Cancer Treatment Data: Abpro's HER2 Therapy Selected for Major AACR Showcase - Stock Titan
Abpro Chief Executive Ian Chan Departs -March 11, 2025 at 04:42 am EDT - Marketscreener.com
Abpro Statement on the Departure of Former CEO Ian Chan - The Manila Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):